Nonsense-mediated mRNA decay as a gatekeeper of neoantigen expression: Bridging RNA surveillance and tumor...

Area of Science:

• Molecular Biology
• Cancer Immunology
• RNA Biology

Background:

• Nonsense-mediated mRNA decay (NMD) is a crucial RNA surveillance pathway that degrades aberrant mRNAs with premature termination codons (PTCs).
• NMD influences tumor immunogenicity by regulating the expression of tumor neoantigens, which are targets for anti-cancer immune responses.
• Many cancer-associated mutations generate PTCs, leading to NMD-mediated degradation of potentially immunogenic neoantigenic peptides.

Purpose of the Study:

• To review the role of NMD in regulating tumor neoantigens and cancer immunogenicity.
• To explore the therapeutic potential of NMD inhibition in cancer immunotherapy.
• To bridge the understanding between RNA biology and clinical cancer immunotherapy.

Main Methods:

• Literature review of NMD pathways and their impact on tumor neoantigens.
• Analysis of how NMD affects the generation and presentation of neoantigens.
• Discussion of NMD inhibition strategies for cancer therapy.

Main Results:

• NMD actively suppresses the production of neoantigens by degrading transcripts containing PTCs generated from tumor-specific mutations.
• Inhibition of NMD can increase the pool of neoantigenic peptides, thereby enhancing tumor immunogenicity.
• Targeting NMD offers a novel approach to potentiate anti-tumor immune responses.

Conclusions:

• NMD plays a significant role in limiting the immunogenic potential of tumors.
• NMD inhibition represents a promising strategy for enhancing cancer immunotherapy efficacy.
• Further research into NMD modulation could lead to new precision cancer therapies.